Cox, L., & Khan, I. (2025). Bigger than sport: the enhanced games and the commodification of telehealth, testosterone, and dependency. Harm Reduction Journal, 22(1), 180.

Piatkowski, T., Kill, E., Weith, S., Reeve, S., Cox, L., Coomber, R., ... & Ferris, J. (2025). Making ‘safer injecting’matter for people who inject image and performance enhancing drugs. Health, 13634593251388294.

Cox, L., & Piatkowski, T. (2026). Eat clen? The normalisation of harmful clenbuterol use within digital fitness cultures. Performance Enhancement & Health, 14(1), 100391.

Cox, L., Piatkowski, T., & Dunn, M. (2025). “Injecting yourself there is stigma around it; taking a few tablets is not too bad, is it?”: understanding perceptions and preferences of anabolic-androgenic steroid route of administration. Harm Reduction Journal, 22(1), 128.

Cook, J. E., Bloodworth, A., Cox, L. T. J., & McNamee, M. (2025). The ethics of sports integrity investigations and the power of sport integrity bodies to compulsorily demand information and personal devices from athletes. International Journal of Sport Policy and Politics, 17(3), 487-507.

Cox, L., Piatkowski, T., Dunn, M. (2025). Injecting yourself there is stigma around it; taking a few tablets is not too bad, is it?”: Understanding perceptions and preferences of anabolic-androgenic steroid route of administration". Harm Reduction Journal.

Cox, L., Piatkowski, T., Turnock, L. (2025). Anabolic steroid coaching certification in India: The role of capital in digital fitness spaces. Drugs: Education, Prevention and Policy, 1-12.

Fife, N. T., Shaw, A. L., Stebbings, G. K., Chollier, M., Cox, L., Harvey, A. N., ... & Heffernan, S. M. (2025). Eligibility of Athletes With a Difference in Sex Development in Elite Sport: Opinions of National, Elite and World Class Athletes. European Journal of Sport Science, 25(5), e12300.

Akrigg, K., Cox, L., Turnock, L. A., Richardson, A., & Piatkowski, T. (2025). If you find me on the floor, stick some sugar in my mouth: The social production (and protection) of insulin risk among IPED communities. Drugs: Education, Prevention and Policy, 1-12.

Piatkowski, T., Cox, L., van de Ven, K., & McVeigh, J. (2025). The material practices and social dimensions of community care among people who use, produce, and supply image and performance enhancing drugs. Addiction Research & Theory, 1-8.

Piatkowski, T., Akrigg, K., Cox, L., Bradshaw, A., & Vigorous, S. (2025). Anything but androgens: How image and performance enhancing drug consumers manage body composition and health through off-label use of medicines. Performance Enhancement & Health, 100329.

Williams, A. G., Heffernan, S. M., Herbert, A. J., Hamilton, B. R., Sánchez, F. J., Gollish, S., Cox, L., & Stebbings, G. K. (2024). Fair and Safe Eligibility Criteria for Women's Sport: The Proposed Testing Regime Is Not Justified, Ethical, or Viable. Scandinavian Journal of Medicine & Science in Sports, 34(11), e14753.

Cox, L., & Piatkowski, T. (2024). Influencers and ‘brain building’smart drugs: A content analysis of services and market activities of nootropic influencers over social media. Performance Enhancement & Health, 12(4), 100289.

Cox, L. T. J., & Piatkowski, T. (2024). Enhancing autonomy through the ‘Enhanced Games’. Performance Enhancement & Health, 12(4), 100296.

Piatkowski, T., Cox, L., & Collins, R. (2024). The ethics of enhancement among image and performance enhancing drug coaches. Health Sociology Review, 1-15.

Cox, L., Piatkowski, T., & McVeigh, J. (2024). “I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm. Drugs: Education, Prevention and Policy, 1-13.

Piatkowski, T., Vigorous, S., Cox, L., & McVeigh, J. (2024). “You could try this compound, but it might send you nuts”: how steroid suppliers perceive the underground market and their ‘hybrid’role within it. Deviant Behavior, 1-12.

Piatkowski, T., Cox, L., Gibbs, N., Turnock, L., & Dunn, M. (2024). ‘The general concept is a safer use approach’: how image and performance enhancing drug coaches negotiate safety through community care. Drugs: Education, Prevention and Policy, 1-9.

Piatkowski, T., & Cox, L. T. J. (2024). ‘Insulin is super dangerous if you don't know what you're doing’: Situating the risks of insulin within the image and performance enhancing drug community. Drug and Alcohol Review.

Paoli, L., & Cox, L. T. J. (2024). Across the spectrum of legality: the market activities of influencers specialized in steroids and other performance and image enhancing drugs. International Journal of Drug Policy, 123, 104246.

Turnock, L., Gibbs, N., Cox, L., & Piatkowski, T. (2023). Big business: The private sector market for image and performance enhancing drug harm reduction in the UK. International Journal of Drug Policy, 122, 104254.

Cox, L. T. J., & Paoli, L. (2023). Social media influencers, YouTube & performance and image enhancing drugs: A narrative-typology. Performance Enhancement & Health, 11(4), 100266.

Constandt, B., Vertommen, T., Cox, L., Kavanagh, E., Kumar, B. P., Pankowiak, A., & Woessner, M. (2023). Quid interpersonal violence in the sport integrity literature? A scoping review. Sport in Society, 1-19.

Cox, L. T. J., McNamee, M., Petróczi, A., & Bloodworth, A. (2023). Why size matters; rugby union and doping. Performance Enhancement & Health, 11(2), 100250.

Cox, L., Gibbs, N., & Turnock, L. A. (2023). Emerging anabolic androgenic steroid markets; the prominence of social media. Drugs: Education, Prevention and Policy, 1-14.

Gibbs, N., Cox, L. T. J., & Turnock, L. A. (2022). Continuing the conversation: Anabolics coaching: Emic harm reduction or a public health concern?. Performance Enhancement & Health, 10(3).

Gibbs, N., Cox, L., & Turnock, L. (2022). Anabolics coaching: Emic harm reduction or a public health concern?. Performance Enhancement & Health, 10(3), 100227.

Cox, L., Bloodworth, A., & McNamee, M. (2022). Doping in recreational Welsh Rugby Union; Athletes’ beliefs and perceptions related to Anti-Doping policy and practice. Performance Enhancement & Health, 10(2), 100211.

Cox, L., Bloodworth, A., & McNamee, M. (2017). Olympic doping, transparency, and the therapeutic exemption process. Diagoras: International Academic Journal on Olympic Studies, 1, 55-74. Retrieved from